Literature DB >> 3680498

Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man.

A Consoli1, F Kennedy, J Miles, J Gerich.   

Abstract

Current isotopic approaches underestimate gluconeogenesis in vivo because of Krebs cycle carbon exchange and the inability to measure intramitochondrial precursor specific activity. We therefore applied a new isotopic approach that theoretically overcomes these limitations and permits quantification of Krebs cycle carbon exchange and the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output. [6-3H]Glucose was infused to measure overall glucose output; [2-14C]acetate was infused to trace phosphoenolpyruvate gluconeogenesis and to calculate Krebs cycle carbon exchange as proposed by Katz. Plasma [14C]3-OH-butyrate specific activity was used to estimate intramitochondrial acetyl coenzyme A (CoA) specific activity, and finally the ratio between plasma glucose 14C-specific activity and the calculated intracellular phosphoenolpyruvate 14C-specific activity was used to determine the relative contributions of gluconeogenesis and glycogenolysis to overall glucose output. Using this approach, acetyl CoA was found to enter the Krebs cycle at twice (postabsorptive subjects) and three times (2 1/2-d fasted subjects) the rate of pyruvate, respectively. Gluconeogenesis in postabsorptive subjects (3.36 +/- 0.20 mumol/kg per min) accounted for 28 +/- 2% of overall glucose output and increased twofold in subjects fasted for 2 1/2-d (P less than 0.01), accounting for greater than 97% of overall glucose output. Glycogenolysis in postabsorptive subjects averaged 8.96 +/- 0.40 mumol/kg per min and decreased to 0.34 +/- 0.08 mumol/kg per min (P less than 0.01) after a 2 1/2-d fast. Since these results agree well with previously reported values for gluconeogenesis and glycogenolysis based on determinations of splanchnic substrate balance and glycogen content of serial liver biopsies, we conclude that the isotopic approach applied herein provides an accurate, noninvasive measurement of gluconeogenesis and glycogenolysis in vivo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3680498      PMCID: PMC442384          DOI: 10.1172/JCI113206

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

Review 1.  Muscle amino acid metabolism and gluconeogenesis.

Authors:  N B Ruderman
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

2.  Influences of glucose loading and of injected insulin on hepatic glucose output.

Authors:  R STEELE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

3.  The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man.

Authors:  A J Garber; P E Cryer; J V Santiago; M W Haymond; A S Pagliara; D M Kipnis
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

4.  Gluconeogenesis in the kidney cortex. Quantitative estimation of carbon flow.

Authors:  R Rognstad; J Katz
Journal:  J Biol Chem       Date:  1972-10-10       Impact factor: 5.157

5.  Liver glycogen in man--the effect of total starvation or a carbohydrate-poor diet followed by carbohydrate refeeding.

Authors:  L H Nilsson; E Hultman
Journal:  Scand J Clin Lab Invest       Date:  1973-12       Impact factor: 1.713

6.  Alanine and gluconeogenesis in man: effect of ethanol.

Authors:  R A Kreisberg; A M Siegal; W C Owen
Journal:  J Clin Endocrinol Metab       Date:  1972-05       Impact factor: 5.958

7.  The fate of isotopic carbon in kidney cortex synthesizing glucose from lactate.

Authors:  H A Krebs; R Hems; M J Weidemann; R N Speake
Journal:  Biochem J       Date:  1966-10       Impact factor: 3.857

8.  On gluconeogenesis of human liver. Accelerated hepatic glucose formation induced by increased precursor supply.

Authors:  G Dietze; M Wicklmayr; K D Hepp; W Bogner; H Mehnert; H Czempiel; H G Henftling
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

9.  Glycerol turnover and oxidation in man.

Authors:  W M Bortz; P Paul; A C Haff; W L Holmes
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

10.  Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus.

Authors:  J Wahren; P Felig; E Cerasi; R Luft
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

View more
  24 in total

1.  Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.

Authors:  M K Hellerstein; R A Neese; P Linfoot; M Christiansen; S Turner; A Letscher
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Glucose turnover and gluconeogenesis in human pregnancy.

Authors:  S Kalhan; K Rossi; L Gruca; E Burkett; A O'Brien
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 3.  The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

Authors:  Romana Stark; Richard G Kibbey
Journal:  Biochim Biophys Acta       Date:  2013-10-28

Review 4.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

5.  Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.

Authors:  A W Thorburn; B Gumbiner; F Bulacan; P Wallace; R R Henry
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

6.  Inhibition of NF-κB Reduces Renal Inflammation and Expression of PEPCK in Type 2 Diabetic Mice.

Authors:  Qianling Liu; Liangyan Zhang; Wei Zhang; Qiufa Hao; Wei Qiu; Yubing Wen; Haiyun Wang; Xuemei Li
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

7.  Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors in the Management Of Type-2 Diabetes: A Drug Class Overview.

Authors:  Juan F Mosley; Lillian Smith; Emily Everton; Chris Fellner
Journal:  P T       Date:  2015-07

8.  Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine.

Authors:  M Stumvoll; U Chintalapudi; G Perriello; S Welle; O Gutierrez; J Gerich
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Glucose and urea production and leucine, ketoisocaproate and alanine fluxes at supraphysiological plasma adrenaline concentrations in volunteers.

Authors:  H Ensinger; K Träger; W Geisser; T Anhäupl; F W Ahnefeld; J Vogt; M Georgieff
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

10.  Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats.

Authors:  A Giaccari; L Rossetti
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.